Biotech

News

Double IPOs headline this week's biotech financings

This week saw two $250 million-plus initial public offering (IPO) filings for Neumora Therapeutics and RayzeBio, plus a record third-round financing for Generate Biomedici

News

Apollo, Nimbus lead bumper week for biotech financings

This week saw a series of big-ticket funding rounds for biotech companies, with Apollo Therapeutics and Nimbus Therapeutics both pulling in upwards of $200 million, in a p

News

Biotech investment in UK ticks up in Q2

Despite the economic downturn, UK life sciences companies raised a healthy £382 million ($486 million) in new financing in the second quarter of the year, with venture cap

News

Medicxi co-founder and partner Francesco De Rubertis

Medicxi primes its latest $400m biotech fund

Anglo-Swiss life sciences investment company Medicxi has raised $400 million for its fourth fund, which will focus on supporting 'asset-centric' companies at all stages of

News

Humanigen facing bankruptcy as reverse merger fails

Three years ago, Humanigen was riding high with a COVID-19 therapy in late-stage testing and shares worth upwards of $20 apiece.

News

London’s life sciences skyscraper gets planning consent

Plans for a major life sciences development at Canary Wharf in London, UK, have been approved by the local authorities, allowing the project to go ahead.

Double IPOs headline this week's biotech financings

Apollo, Nimbus lead bumper week for biotech financings

Biotech investment in UK ticks up in Q2

Medicxi primes its latest $400m biotech fund

Humanigen facing bankruptcy as reverse merger fails

London’s life sciences skyscraper gets planning consent

NICE changes stance on Genmab's cervical cancer drug

Discover a new era of healthcare panel engagement: Grounded ...

Biotech

Editor's Picks